Literature DB >> 26433550

Cooperative Group Trials in the Community Setting.

James Lloyd Wade1, Nicholas J Petrelli2, Worta McCaskill-Stevens3.   

Abstract

Over the last 40 years the National Cancer Institute (NCI) has created a vibrant public-private partnership for the implementation of NCI-sponsored cooperative group (Network) clinical trials throughout the United States and Canada. Over these four decades, the cancer clinical trials process has become more complex more precise and more resource intensive. During this same time period, financial resources to support the NCI community research initiative have become more constrained. The newest manifestation of NCI-sponsored community based cancer clinical trial research, known as the National Community Oncology Research Program (NCORP) began initial operation August 1, 2014. We describe several key strategies that community sites may use to not only be successful but to thrive in this new financially austere research environment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26433550      PMCID: PMC4692715          DOI: 10.1053/j.seminoncol.2015.07.011

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  5 in total

1.  Clinical trial investigator status: you need to earn it.

Authors:  Nicholas J Petrelli; Stephen Grubbs; Kandie Price
Journal:  J Clin Oncol       Date:  2008-05-20       Impact factor: 44.544

Review 2.  Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program.

Authors:  Lori M Minasian; William R Carpenter; Bryan J Weiner; Darrell E Anderson; Worta McCaskill-Stevens; Stefanie Nelson; Cynthia Whitman; Joseph Kelaghan; Ann M O'Mara; Arnold D Kaluzny
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

3.  Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.

Authors:  Bryan J Weiner; Sara R Jacobs; Lori M Minasian; Marjorie J Good
Journal:  J Oncol Pract       Date:  2012-05-01       Impact factor: 3.840

4.  Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Authors:  P N Lara; R Higdon; N Lim; K Kwan; M Tanaka; D H Lau; T Wun; J Welborn; F J Meyers; S Christensen; R O'Donnell; C Richman; S A Scudder; J Tuscano; D R Gandara; K S Lam
Journal:  J Clin Oncol       Date:  2001-03-15       Impact factor: 44.544

5.  The Community Clinical Oncology Program (CCOP) story: review of community oncologists' experiences with clinical research trials in cancer with an emphasis on the CCOP of the National Cancer Institute between 1982 and 1987.

Authors:  R W Frelick
Journal:  J Clin Oncol       Date:  1994-08       Impact factor: 44.544

  5 in total
  6 in total

1.  A Rare Opportunity: Examining the Experience of a New Institutional Review Board.

Authors:  Linda Parreco; Lisa Rooney; Sharon Hampp; Amanda Brown; Lori Minasian
Journal:  J Empir Res Hum Res Ethics       Date:  2019-05-20       Impact factor: 1.742

2.  Current Activities of the Coalition of Cancer Cooperative Groups.

Authors:  Monica M Bertagnolli; Susan M Blaney; Charles D Blanke; Walter J Curran; Janet Dancey; Robert S Mannel; Peter J O'Dwyer; Mitchell D Schnall; Norman Wolmark
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

3.  A Short History of Bernard Fisher's Contributions to Randomized Clinical Trials.

Authors:  Stewart Anderson
Journal:  Clin Trials       Date:  2022-01-06       Impact factor: 2.599

Review 4.  Interventions to improve the quality of life and survivorship of older adults with cancer: The funding landscape at NIH, ACS and PCORI.

Authors:  Marie Flannery; Supriya Gupta Mohile; William Dale; Neeraj K Arora; Lauren Azar; Erica S Breslau; Harvey Jay Cohen; Efrat Dotan; Basil A Eldadah; Corinne R Leach; Sandra A Mitchell; Julia H Rowland; Arti Hurria
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

5.  The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.

Authors:  Barbara A Conley; Lou Staudt; Naoko Takebe; David A Wheeler; Linghua Wang; Maria F Cardenas; Viktoriya Korchina; Jean Claude Zenklusen; Lisa M McShane; James V Tricoli; Paul M Williams; Irina Lubensky; Geraldine O'Sullivan-Coyne; Elise Kohn; Richard F Little; Jeffrey White; Shakun Malik; Lyndsay N Harris; Bhupinder Mann; Carol Weil; Roy Tarnuzzer; Chris Karlovich; Brian Rodgers; Lalitha Shankar; Paula M Jacobs; Tracy Nolan; Sean M Berryman; Julie Gastier-Foster; Jay Bowen; Kristen Leraas; Hui Shen; Peter W Laird; Manel Esteller; Vincent Miller; Adrienne Johnson; Elijah F Edmondson; Thomas J Giordano; Benjamin Kim; S Percy Ivy
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 11.816

6.  Demographic and Health Behavior Factors Associated With Clinical Trial Invitation and Participation in the United States.

Authors:  Courtney P Williams; Nicole Senft Everson; Nonniekaye Shelburne; Wynne E Norton
Journal:  JAMA Netw Open       Date:  2021-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.